相似文献
1
Pediatric melanoma-The whole (conflicts of interest) story.
Int J Womens Dermatol. 2018 Nov 19;5(2):110-115. doi: 10.1016/j.ijwd.2018.10.020. eCollection 2019 Jun.
2
Pediatric Melanoma and Drug Development.
Children (Basel). 2018 Mar 20;5(3):43. doi: 10.3390/children5030043.
3
Do the European Medicines Agency Decisions Hurt Pediatric Melanoma Patients?
Clin Ther. 2017 Feb;39(2):253-265. doi: 10.1016/j.clinthera.2017.01.009. Epub 2017 Jan 31.
4
The Meanings of "Pediatric Drug Development".
Ther Innov Regul Sci. 2019 Nov;53(6):767-774. doi: 10.1177/2168479018812060. Epub 2018 Dec 9.
5
The impact of the written request process on drug development in childhood cancer.
Pediatr Blood Cancer. 2013 Apr;60(4):531-7. doi: 10.1002/pbc.24346. Epub 2013 Jan 17.
6
European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
Clin Ther. 2014 Feb 1;36(2):163-77. doi: 10.1016/j.clinthera.2014.01.009.
7
EMA and FDA psychiatric drug trial guidelines: assessment of guideline development and trial design recommendations.
Epidemiol Psychiatr Sci. 2021 Apr 30;30:e35. doi: 10.1017/S2045796021000147.
8
Melanoma Vaccine--AVAX Technologies: DNP-VACC, M-Vax.
BioDrugs. 2003;17(1):69-72. doi: 10.2165/00063030-200317010-00007.
9
Are Regulatory Age Limits in Pediatric Melanoma Justified?
Curr Ther Res Clin Exp. 2019 Jan 18;90:113-118. doi: 10.1016/j.curtheres.2019.01.003. eCollection 2019.
10
Global Pediatric Drug Development.
Curr Ther Res Clin Exp. 2019 Feb 13;90:135-142. doi: 10.1016/j.curtheres.2019.02.001. eCollection 2019.
引用本文的文献
1
Did pediatric drug development advance epilepsy treatment in young patients? It is time for new research goals.
World J Methodol. 2024 Jun 20;14(2):92371. doi: 10.5662/wjm.v14.i2.92371.
2
Identification of Potential Core Genes Between Primary and Metastatic Malignant Melanoma and Analysis of Their Immune Correlation.
Int J Gen Med. 2022 Jan 11;15:379-391. doi: 10.2147/IJGM.S338890. eCollection 2022.
3
COVID-19 and Treatment and Immunization of Children-The Time to Redefine Pediatric Age Groups is Here.
Rambam Maimonides Med J. 2021 Apr 29;12(2):e0010. doi: 10.5041/RMMJ.10433.
4
Too Many Avoidable Suicides Occur Worldwide in Young Patients.
Rambam Maimonides Med J. 2019 Oct 29;10(4):e0026. doi: 10.5041/RMMJ.10374.
5
The Challenges of Pediatric Drug Development.
Curr Ther Res Clin Exp. 2019 Jan 26;90:128-134. doi: 10.1016/j.curtheres.2019.01.007. eCollection 2019.
6
Questionable Industry-Sponsored Postneonatal Pediatric Studies in Slovenia.
Curr Ther Res Clin Exp. 2019 Jan 18;90:86-91. doi: 10.1016/j.curtheres.2019.01.002. eCollection 2019.
7
Rational Use of Medicine in Children-The Conflict of Interests Story. A Review.
Rambam Maimonides Med J. 2019 Jul 18;10(3):e0018. doi: 10.5041/RMMJ.10371.
本文引用的文献
1
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer.
Eur J Cancer. 2018 Sep;100:27-34. doi: 10.1016/j.ejca.2018.05.002. Epub 2018 Jun 21.
2
Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industry.
Pediatr Dermatol. 2018 May;35(3):303-322. doi: 10.1111/pde.13452. Epub 2018 Mar 30.
3
Contrasting features of childhood and adolescent melanomas.
Pediatr Dermatol. 2018 May;35(3):354-360. doi: 10.1111/pde.13454. Epub 2018 Mar 23.
4
Pediatric Melanoma and Drug Development.
Children (Basel). 2018 Mar 20;5(3):43. doi: 10.3390/children5030043.
5
Most adolescents' melanomas are conventional malignant adult-type melanomas.
Eur J Cancer. 2018 May;95:117-119. doi: 10.1016/j.ejca.2018.01.080. Epub 2018 Feb 20.
6
Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank.
J Am Heart Assoc. 2018 Feb 10;7(4):e007283. doi: 10.1161/JAHA.117.007283.
7
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
N Engl J Med. 2018 Feb 1;378(5):439-448. doi: 10.1056/NEJMoa1709866.
8
Joint adolescent-adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform-ACCELERATE.
Ann Oncol. 2018 Mar 1;29(3):766-771. doi: 10.1093/annonc/mdy002.
9
Review: Oncolytic virotherapy, updates and future directions.
Oncotarget. 2017 May 31;8(60):102617-102639. doi: 10.18632/oncotarget.18309. eCollection 2017 Nov 24.
10
Monitoring and management of hypertension with obesity in adolescents.
Integr Blood Press Control. 2017 Nov 20;10:33-39. doi: 10.2147/IBPC.S125094. eCollection 2017.
Zotero 插件